Antengene Announces Poster Presentation of ATG-022 and ATG-037 at ESMO 2026 SHANGHAI and HONG KONG, July 20, 2026 /PRNewswire/ — Antengene Corporation Limited… CISION PRNewswireJuly 20, 2026
Press ReleaseAscentium Welcomes MGI Dobbyn Carafa, Strengthening Advisory Capability in Australia MELBOURNE, Australia, July 20, 2026 /PRNewswire/ — Ascentium, a leading global business services… CISION PRNewswireJuly 20, 2026
Press ReleaseShinsung Materials Leads Clean Beauty with High-Performance Cosmetic Ingredients, Differentiated Processes and Eco-Friendly Practices Strengthens global competitiveness by producing widely used water-soluble UV filters, naturally derived… CISION PRNewswireJuly 20, 2026
Press ReleaseShort Documentary "South China Sea: Our Story" Highlights Regional Peace and Cooperation BEIJING, July 20, 2026 /PRNewswire/ — As the waters of the South… CISION PRNewswireJuly 20, 2026
Press ReleaseMoore Global's Strongest Growth Lies Ahead, Says New CEO Vivienne Muir LONDON, July 20, 2026 /PRNewswire/ — Moore Global today announced the appointment… CISION PRNewswireJuly 20, 2026
Offering Chinese wisdom, solutions, strength for addressing major issues facing humanity: Global impact of CPC's 105th founding anniversary BEIJING, July 20, 2026 /PRNewswire/ — A report from People’s Daily: In… CISION PRNewswireJuly 20, 2026
Fostering new opportunities in the Greater Bay Area and Asia's Pharmaceutical Industry SHANGHAI, July 20, 2026 /PRNewswire/ — Following the landmark success of CPHI… CISION PRNewswireJuly 20, 2026
Akeso Doses First Patient in Phase II Study of Novel TROP2/Nectin-4 Bispecific ADC (AK146D1) in Combination with Ivonescimab for Advanced NSCLC HONG KONG, July 20, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or… CISION PRNewswireJuly 20, 2026
